Biopsy is a medical procedure of the removal of a sample from a tissue for diagnosis and examination of diseases. Needle and surgical biopsy are the main types of biopsies. Breast biopsy is the surgical or minimally invasive procedure of removal of cells from an abnormal part in the breast for examination and diagnosis. Breast biopsies are done to check whether a lump in the breast detected in a physical examination, mammography or other imaging studies is cancerous and if yes, whether it is benign or malignant. The patient is positioned lying face up on the examination table or turned slightly to the side and is given a local anesthetic into the breast to numb it. Pressing the transducer to the breast, the sonographer or radiologist locates the lesion. A very small nick is made in the skin at the site where the biopsy needle is to be inserted. The radiologist, monitoring the lesion site with the ultrasound probe, inserts the needle and advances it directly into the mass.
Breast Biopsy Device Market: Drivers & Restraints
Global breast biopsy device market is witnessing high growth due to increasing prevalence of breast cancer. Breast biopsy is minimally invasive, leaves little or no scarring and can be performed in less than an hour. It is an efficient method to diagnose the presence of calcium deposits or masses that are not visible in imaging methods.Owing to lesser recovery time, people are opting for breast biopsy even in slightest probability of a suspicious mass, microcalcifications, distortion in the structure of the breast tissue, an area of abnormal tissue change or in the presence of a new mass or area of calcium deposits. As a result, the global breast biopsy device market is expected to register healthy CAGR during the forecast period. Risks such as bleeding during the procedure, discomfort and infection could hamper market growth through 2026.
Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1496
Breast Biopsy Device Market: Segmentation
The global breast biopsy device market is classified on the basis of procedure type, end use and region.
Based on procedure type, the global breast biopsy device market is segmented into the following:
- Needle Biopsy
- Fine needle aspiration biopsy
- Core needle biopsy
- Vacuum-assisted breast biopsy
- Surgical Biopsy
- Incisional biopsy
- Excisional biopsy
Based on end use, the global breast biopsy device market is segmented into the following:
- Ambulatory Surgical Centres
- Diagnostic Laboratories
Breast Biopsy Device Market: Overview
Biopsy is majorly done for the diagnosis of various types of cancer. Growing prevalence of various forms of cancer and infectious diseases are expected to drive the global biopsy device market which is anticipated to have a positive effect on global breast biopsy device market. Needle biopsy, particularly core needle biopsy is the most commonly conducted procedure type in breast biopsy and is expected to remain the dominant sub-segment among others. Breast biopsies are usually done on an outpatient basis. The ambulatory surgical centres segment is projected to register fastest CAGR during the forecast period.
Breast Biopsy Device Market: Region wise Overview
Geographically, global breast biopsy device market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), Japan, Middle East and Africa (MEA).North America is anticipated to lead the global breast biopsy device market due to relatively greater prevalence of breast cancer in the region. Global breast biopsy device market is largely concentrated in North America and Europe, which is estimated to account for more than 50% of the market share. Owing to a large patient population pool in China and India, breast biopsy device market is projected to grow at a significant CAGR during the forecast period.
Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1496
Breast Biopsy Device Market: Key Players
Key players in global breast biopsy device market are Leica Biosystems, C.R. Bard Inc., NuVue Therapeutics, Argon Medical Devices, Inc., Becton, Dickinson and Company to name a few.